PFS
PRTK

Prospera Financial Services’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Prospera Financial Services’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,465
Closed -$29K – 972
2022
Q3 		$29K Buy
11,465
+7,000
+157% +$17.4K ﹤0.01% 824
2022
Q2 		$9K Hold
4,465
– – ﹤0.01% 1378
2022
Q1 		$13K Buy
+4,465
New +$16.8K ﹤0.01% 1938

Other funds holding PRTK

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Prospera Financial Services's PRTK Position: Q4 2022 in Review

Prospera Financial Services sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2022, closing a stake of 11,465 shares — an estimated $29K sold.

Prospera Financial Services first reported a position in PRTK in Q1 2022 and held it in 3 quarters. The position peaked at $29K in Q3 2022. 76 funds tracked by Wall St. Rank hold PRTK as of Q4 2022.

  • Prospera Financial Services reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Prospera Financial Services sold 11,465 Paratek Pharmaceuticals, Inc. shares in Q4 2022, an estimated $29K.
  • Prospera Financial Services first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2022 and held it in 3 quarters.
  • Prospera Financial Services's Paratek Pharmaceuticals, Inc. position peaked at $29K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2022.

Based on Prospera Financial Services's 13F filing for Q4 2022, filed 8 Feb 2023.